A letter signed by nearly 400 health experts asked the FDA to use its vaccine advisory panel when reviewing data on coronavirus trials, as reported The New York Times.
The coalition urged the regulator to conduct full safety and efficacy reviews of potential COVID-19 vaccines before making the products widely available to the public.
The group called on FDA commissioner Stephen Hahn to be forthcoming about the agency’s deliberations over whether to approve any new vaccine, in order to gain the public's trust.
"We must be able to witness a transparent and rigorous FDA approval process that is devoid of political considerations," the letter noted.
"Collaborations between scientists, the pharmaceutical industry and the federal government may bring us to a remarkable and historic achievement," the letter said, "but an effective vaccine will only be truly useful if a large proportion of the public is willing to take it."
In an effort to reassure the public, Hahn said recently that he would seek the advice of the regulator's Vaccines and Related Biological Products Advisory Committee.
To read more NewsPoints articles, click here.